Dopamine Reuptake Inhibitors
Links shared publicly online about this topic
Ssris (Selective Serotonin Reuptake Inhibitors) - NHS Choices
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on January 2, 2011 at 4:41 am By:
Healthcare TweetMeme Health Social Media
Ssris (Selective Serotonin Reuptake Inhibitors) - NHS Choices http://retwt.me/1Qp56 (via @AegiSite)
Selective serotonin-reuptake inhibitors and recovery after stroke : The Lancet Neurology
thelancet.com — “Selective serotonin-reuptake inhibitors and recovery after stroke. By - Robert G Robinson, Harold P Adams” View full resource at thelancet.com
Most Recently Shared on January 21, 2011 at 12:03 am By:
[Comment] Selective serotonin-reuptake inhibitors and recovery after stroke: Motor impairments are an important ... http://bit.ly/ibew9T
Toxicity, Selective Serotonin Reuptake Inhibitor: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed medications for the treatment of depression, obsessive-compulsive disorder, bulimia, anorexia nervosa, panic disorder, and social phobia. The majority of all antidepressants prescribed in the United States are from ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 4, 2010 at 2:02 am By:
Susan Scroggins Active Health Library and Health Advocate
SSRIs are sometimes prescribed to treat depression & other social disorders. They can be toxic. Learn signs & symptoms. http://bit.ly/97YIyY
Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July/August)
theannals.com — “Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July/August)” View full resource at theannals.com
Most Recently Shared on July 13, 2011 at 6:07 am By:
Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July... http://bit.ly/qvC8fq
Selective Serotonin Reuptake Inhibitor Use During Pregnancy May Increase Risk of Autism Spectrum Disorders | ThirdAge
thirdage.com — “Selective serotonin reuptake inhibitor use during pregnancy may increase a child's risk of autism spectrum disorders.” View full resource at thirdage.com
Most Recently Shared on July 4, 2011 at 11:55 pm By:
Selective Serotonin Reuptake Inhibitor Use During Pregnancy May Increase Risk of Autism Spectrum Disorders http://bit.ly/myd6lp
Antidepressants: Selective Serotonin And Norepinephrine Reuptake Inhibitor Drugs Show Benefits In German Study
feeds.sciencedaily.com — “Patients with depression benefit from taking venlafaxine and duloxetine, two drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor drug class. This is the conclusion of a report published by German researchers. Clinical comparisons with a sham drug (placebo) show that patients respond better to the therapy, suffering less from the symptoms of depression.” View full resource at feeds.sciencedaily.com
Most Recently Shared on August 28, 2009 at 1:16 pm By:
Antidepressants: Selective Serotonin And Norepinephrine Reuptake Inhibitor Drugs Show Benefits In German Study: .. http://bit.ly/SbO3V
Milnacipran: A serotonin and norepinephrine reuptake inhibitor for the management of fibromyalgia syndrome - - ModernMedicine
modernmedicine.com — “Milnacipran was recently approved by FDA for the management of fibromyalgia syndrome. Clinical trials have demonstrated that this agent may be a reasonable alternative or adjunct therapy for patients with fibromyalgia syndrome who are unable to tolerate first-line tricyclic antidepressant therapy.” View full resource at modernmedicine.com
Most Recently Shared on July 2, 2009 at 4:40 pm By:
Milnacipran: A serotonin and norepinephrine reuptake inhibitor for ... - Modern Medicine http://tinyurl.com/lbwj9z
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder (April) -- Wu et al., 10.1345/aph.1P482 -- The Anna
theannals.com — “Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder (April) -- Wu et al., 10.1345/aph.1P482 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on March 18, 2011 at 2:57 am By:
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternativ... http://bit.ly/fhSCip
[Serotonin-noradrenalin reuptake inhibitors in the... [Tijdschr Psychiatr. 2009] - PubMed result
medworm.com — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at medworm.com
Most Recently Shared on November 14, 2009 at 6:16 pm By:
[Serotonin-noradrenalin reuptake inhibitors in the treatment of non-malignant pain syndromes; a systematic revi.. http://bit.ly/FxuCB
Serotonin-norepinephrine reuptake inhibitors for p... [Curr Neuropharmacol. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on June 2, 2010 at 10:44 am By:
FibroAction Health Organization
On Pubmed: Serotonin-norepinephrine reuptake inhibitors for pain control: premise and pr... http://tinyurl.com/37oetpz #fibro #fibromyalgia
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
fda.gov — “Conflicting results from different studies makes it premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN.” View full resource at fda.gov
Most Recently Shared on December 15, 2011 at 2:00 pm By:
Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
journals.elsevierhealth.com — “Biological Psychiatry, Volume 67, Issue 5, Pages 439-445, 1 March 2010, Authors:Ciara McCabe; Zevic Mishor; Philip J. Cowen; Catherine J. Harmer” View full resource at journals.elsevierhealth.com
Most Recently Shared on February 12, 2010 at 2:56 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
SSRI antidepressants may dampen brain reward response as well as response to adverse stimuli. http://ow.ly/16JG6
How Serotonin Reuptake Inhibitors Work: Understanding More Fundamental Mechanisms of Action - Psychiatry
psychiatry.jwatch.org — “Several lines of evidence suggest that in adults, antidepressant therapies enhance neurogenesis in the hippocampus, but how this process occurs has been unclear. These researchers studied the effects of fluoxetine in mice and in humans. . . .” View full resource at psychiatry.jwatch.org
Most Recently Shared on January 17, 2012 at 7:15 pm By:
Jennie Byrne MD PhD Doctor, Psychiatrist, Physician, and PhD
How do SSRI antidepressants work? http://t.co/nMIbpPnu
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects - Gentile - 2011 - Acta Psychiatrica Scandinavica - Wiley Online Library
onlinelibrary.wiley.com — “Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects - Gentile - 2011 - Acta Psychiatrica Scandinavica - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on January 26, 2011 at 12:28 pm By:
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects: Conclusion... http://bit.ly/eIErcZ
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
7thspace.com — “Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series - up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment, Headlines, Recipes and more. A place for the whole family featuring many different sections to chose from.” View full resource at 7thspace.com
Most Recently Shared on February 28, 2011 at 6:53 pm By:
Peter H Brown Doctor and Psychologist
Switching from serotonin reuptake inhibitors to agomelatine in patients with ...: However, OCD is character... http://bit.ly/f1kceB #ocd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Healthcare TweetMeme
Tracking Twitter Healthcare Memes from TweetMeme
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
Advertisement
